帕金森病脑深部电刺激:不同随访时间随机试验结果的荟萃分析
该荟萃分析纳入13项随机对照试验(6个原始队列),比较丘脑底核(STN)与苍白球内侧部(GPi)脑深部电刺激(DBS)治疗晚期帕金森病(PD)的疗效。36个月时两组运动评分与日常生活活动无差异;STN组药物剂量显著减少(WMD -365.46,95%CI -599.48至-131.44,p=0.002);GPi组贝克抑郁量表评分显著更优(WMD 2.53,95%CI 0.99-4.06,p=0.001)。作者认为两者运动获益相似,需进一步长期研究。
要点
- 36个月时GPi与STN DBS的运动评分和日常生活活动无差异。
- STN DBS药物剂量减少更显著(WMD -365.46,95%CI -599.48至-131.44,p=0.002)。
- GPi DBS贝克抑郁量表评分更优(WMD 2.53,95%CI 0.99-4.06,p=0.001)。
核心结论
- GPi与STN DBS治疗帕金森病的运动获益相似。
- STN DBS允许更大程度减少药物,但GPi DBS在情绪方面优势更显著,该差异在36个月时持续存在。
- 需要进一步长期研究。
研究设计与样本
- 研究为随机对照试验的荟萃分析,检索MEDLINE、Embase、CENTRAL、Web of Science和CINAHL数据库及试验注册库、会议论文集和期刊目录。
- 初筛623项研究(数据库检索615项、手工回顾参考文献7项、投稿前重复筛选文献1项),19项全文审查,13项纳入定量荟萃分析(6个原始队列)。
- 采用Cochrane Collaboration工具评估偏倚风险,GRADE证据概览工具评估证据质量。
- 比较运动评分、药物剂量减少、日常生活活动、抑郁、异动症和不良事件。
- 探索疾病病程(预先设定)和研究内男性患者比例(事后)作为潜在亚组。
主要发现
- 36个月时未发现运动评分或日常生活活动差异。
- STN刺激显著减少药物(5项研究,加权均数差[WMD] -365.46,95%CI -599.48至-131.44,p=0.002)。
- GPi刺激贝克抑郁量表评分显著更优(3项研究;WMD 2.53,95%CI 0.99-4.06,p=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步长期研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Deep brain stimulation (DBS) is effective in the management of patients with advanced Parkinson's disease (PD). While both the globus pallidus pars interna (GPi) and the subthalamic nucleus (STN) are accepted targets, their relative efficacy in randomized controlled trials (RCTs) has not been established beyond 12 months. The objective of this study was to conduct a meta-analysis of RCTs to compare outcomes among adults with PD undergoing DBS of GPi or STN at various time points, including 36 months of follow-up. METHODS The MEDLINE, Embase, CENTRAL, Web of Science, and CINAHL databases were searched. Registries for clinical trials, selected conference proceedings, and the table of contents for selected journals were also searched. Screens were conducted independently and in duplicate. Among the 623 studies initially identified (615 through database search, 7 through manual review of bibliographies, and 1 through a repeat screen of literature prior to submission), 19 underwent full-text review; 13 of these were included in the quantitative meta-analysis. Data were extracted independently and in duplicate. The Cochrane Collaboration tool was used to assess the risk of bias. The GRADE evidence profile tool was used to assess the quality of the evidence. Motor scores, medication dosage reduction, activities of daily living, depression, dyskinesias, and adverse events were compared. The influence of disease duration (a priori) and the proportion of male patients within a study (post hoc) were explored as potential subgroups. RESULTS Thirteen studies (6 original cohorts) were identified. No difference in motor scores or activities of daily living was identified at 36 months. Medications were significantly reduced with STN stimulation (5 studies, weighted mean difference [WMD] -365.46, 95% CI -599.48 to -131.44, p = 0.002). Beck Depression Inventory scores were significantly better with GPi stimulation (3 studies; WMD 2.53, 95% CI 0.99-4.06 p = 0.001). The motor benefits of GPi and STN DBS for PD are similar. CONCLUSIONS The motor benefits achieved with GPi and STN DBS for PD are similar. DBS of STN allows for a greater reduction of medication, but not as significant an advantage as DBS of GPi with respect to mood. This difference is sustained at 36 months. Further long-term studies are necessary.
引用
- Mansouri A, Taslimi S, Badhiwala JH, et al. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg. 2017. PMID: 28665252. doi:10.3171/2016.11.JNS16715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。